Knowledge

Virchow's triad

Source 📝

124:(1821–1902). However, the elements comprising Virchow's triad were not proposed by Virchow. Neither did he ever suggest a triad to describe the pathogenesis of venous thrombosis. In fact, it was not until decades after Virchow's death that a consensus was reached proposing that thrombosis is the result of alterations in blood flow, vascular endothelial injury, or alterations in the constitution of the blood. Still, the modern understanding of the factors leading to embolism is similar to the description provided by Virchow. Virchow's triad remains a useful concept for clinicians and pathologists alike in understanding the contributors to thrombosis. 32: 309:
surrounding pulmonary embolism, he alluded to many of the factors known to contribute to venous thrombosis. While these factors had already been previously established in the medical literature by others, for unclear reasons they ultimately became known as Virchow's triad. This
726: 608: 502: 317:
Although the concept of the triad is usually attributed to Virchow, he did not include endothelial injury in his description. This has been attributed to a dispute Virchow had with
286:
The origin of the term "Virchow's Triad" is of historical interest, and has been subject to reinterpretation in recent years. While both Virchow's and the modern triads describe
781: 305:, particularly those of the extremities, become dislodged and migrate to the pulmonary vasculature. He published his description in 1856. In detailing the 612: 488: 730: 774: 671: 506: 314:
did not emerge in the literature until long after Virchow's death. One estimate of the first use of the phrase dates it to the early 1950s.
290:, the previous triad has been characterized as "the consequences of thrombosis", and the modern triad as "the causes of thrombosis". 767: 898: 461: 346: 163:, long surgical operations, prolonged immobility (whilst on a long plane or car ride, bed bound during hospitalization), and 467: 1073: 1056: 655: 1135: 1087: 569: 854: 1141: 1127: 1115: 1078: 948: 1268: 844: 601: 247:
The last category, alterations in the constitution of blood, has numerous possible risk factors such as
1223: 1068: 321:, who considered local trauma of primary importance in the development of pulmonary artery thrombosis. 1339: 910: 891: 1309: 1052: 881: 267:, late pregnancy and delivery, race, advanced age, cigarette smoking, hormonal contraceptives, and 336: 159:
The first category, alterations in normal blood flow, refers to several situations. These include
1406: 1401: 1299: 1092: 675: 1213: 1188: 1146: 44: 495: 1208: 1198: 1016: 251:, coagulation factor V Leiden mutation, coagulation factor II G2021A mutation, deficiency of 964: 859: 849: 453:
The Aetiology of Deep Venous Thrombosis: A Critical, Historical and Epistemological Survey
8: 1396: 1203: 1193: 989: 869: 1329: 1011: 969: 816: 633:
Virchow, R. (1856). "Thrombose und Embolie. Gefässentzündung und septische Infektion".
482: 294: 272: 256: 241: 209: 96: 341:. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 396. 1218: 994: 903: 759: 651: 550: 457: 429: 424: 407: 388: 342: 88:) describes the three broad categories of factors that are thought to contribute to 1044: 984: 979: 839: 540: 419: 378: 318: 65: 719: 1324: 1158: 999: 864: 640: 451: 337:
April Wang Armstrong; David E. Golan; Armen H. Tashjian; Ehrin Armstrong (2008).
306: 260: 213: 197: 167:. The equivalence of Virchow's version and the modern version has been disputed. 1349: 1061: 1004: 886: 714: 709: 248: 164: 121: 1390: 1359: 1181: 1176: 1171: 928: 217: 160: 153: 1102: 1369: 811: 554: 433: 392: 252: 229: 205: 193: 189: 1166: 974: 806: 795: 185: 107: 101: 664: 634: 584: 1354: 1319: 1294: 938: 920: 287: 89: 545: 528: 383: 366: 339:
Principles of pharmacology: the pathophysiologic basis of drug therapy
1344: 1289: 876: 225: 221: 118: 172:
Phenomena associated with irritation of the vessel and its vicinity
31: 1258: 1253: 1243: 933: 791: 639:(in German). Frankfurt am Main: Von Meidinger & Sohn. pp.  201: 1304: 1263: 449: 298: 268: 115: 16:
Three factors thought to cause internal blood clots (thrombosis)
1248: 311: 264: 74: 302: 271:. All of these risk factors can cause the situation called 80: 699:. (2nd ed.) London, Norton and Macock, 1686, pp. 64–66. 650:. Canton, Massachusetts: Science History Publications. 789: 636:
Gesammelte Abhandlungen zur wissenschaftlichen Medicin
570:"Venous thrombosis: on the history of Virchow's triad" 77: 71: 754:. New York, Paul B. Hoeber, Inc., 1924, pp 253–278. 445: 443: 188:includes vessel piercings and damages arising from 68: 609:"Response: further reflections on Virchow's Triad" 408:"Virchow and his triad: a question of attribution" 1388: 440: 200:and contact with procoagulant surfaces, such as 529:"Virchow's triad revisited: blood constituents" 184:The second category, injuries and/or trauma to 360: 358: 330: 775: 645: 567: 487:: CS1 maint: multiple names: authors list ( 632: 520: 399: 355: 782: 768: 450:Malone, P. Colm, Agutter, Paul S. (2008). 367:"Virchow's triad revisited: abnormal flow" 293:Rudolf Virchow elucidated the etiology of 30: 544: 423: 405: 382: 526: 503:"Further reflections on Virchow's triad" 132:The triad consists of three components: 1036: 364: 1389: 275:(excessively easy clotting of blood). 763: 577:University of Toronto Medical Journal 752:Thrombosis, in Lectures on Pathology 149:Phenomena of interrupted blood-flow 13: 648:Thrombosis and embolie (1846–1856) 14: 1418: 406:Bagot CN, Arya R (October 2008). 255:III, protein C or S deficiency, 1136:platelet storage pool deficiency 1088:Heparin-induced thrombocytopenia 740:– via Free Online Library. 685:– via Free Online Library. 622:– via Free Online Library. 516:– via Free Online Library. 425:10.1111/j.1365-2141.2008.07323.x 64: 744: 702: 689: 470:from the original on 2022-10-15 456:. Paris: Springer. p. 84. 237:Phenomena of blood-coagulation 204:, shards of foreign materials, 114:It is named after the renowned 855:Activated protein C resistance 646:Matzdorff AC, Bell WR (1998). 626: 561: 1: 697:Several Chirurgical Treatises 533:Pathophysiol. Haemost. Thromb 371:Pathophysiol. Haemost. Thromb 324: 949:Trousseau sign of malignancy 196:. This category is ruled by 127: 104:changes (stasis, turbulence) 7: 1269:Nonthrombocytopenic purpura 845:Antithrombin III deficiency 727:"Virchow's triad revisited" 10: 1423: 1224:Congenital afibrinogenemia 1128:Glanzmann's thrombasthenia 281: 1340:Gastrointestinal bleeding 1279: 1236: 1157: 1142:Hermansky–Pudlak syndrome 1101: 1043: 1029: 957: 919: 911:Antiphospholipid syndrome 892:Essential thrombocythemia 832: 825: 802: 583:: 166–171. Archived from 43: 38: 29: 24: 1310:Subconjunctival bleeding 1116:Bernard–Soulier syndrome 1079:Upshaw–Schulman syndrome 1053:Thrombocytopenic purpura 882:Sticky platelet syndrome 527:Chung I, Lip GY (2003). 1300:Intracranial hemorrhage 259:, changes after severe 1214:Factor XIII deficiency 1194:Hypoprothrombinemia/II 1189:von Willebrand disease 1147:Gray platelet syndrome 568:Dickson, B.C. (2004). 45:Differential diagnosis 1209:Factor XII deficiency 1199:Factor VII deficiency 1017:Renal vein thrombosis 301:occurring within the 965:Deep vein thrombosis 860:Protein S deficiency 850:Protein C deficiency 230:chronic inflammation 1204:Factor X deficiency 1093:May–Hegglin anomaly 870:Prothrombin G20210A 224:, and membranes of 25:Virchow's triad 1330:Pulmonary hematoma 1237:Signs and symptoms 1012:Pulmonary embolism 817:Bleeding diathesis 672:"Virchow's triad?" 295:pulmonary embolism 273:hypercoagulability 257:nephrotic syndrome 242:Hypercoagulability 180:vessel wall injury 176:Endothelial injury 110:injury/dysfunction 97:Hypercoagulability 1384: 1383: 1380: 1379: 1232: 1231: 1219:Dysfibrinogenemia 1103:Platelet function 1025: 1024: 904:Purpura fulminans 546:10.1159/000083844 463:978-1-4020-6649-8 384:10.1159/000083845 348:978-0-7817-8355-2 279: 278: 198:surface phenomena 53: 52: 19:Medical condition 1414: 1045:Thrombocytopenia 1041: 1040: 1034: 1033: 990:Lowenberg's sign 840:Clotting factors 830: 829: 784: 777: 770: 761: 760: 755: 748: 742: 741: 739: 738: 729:. Archived from 723: 717: 706: 700: 693: 687: 686: 684: 683: 674:. Archived from 668: 662: 661: 644: 630: 624: 623: 621: 620: 611:. Archived from 605: 599: 598: 596: 595: 589: 574: 565: 559: 558: 548: 539:(5–6): 449–454. 524: 518: 517: 515: 514: 505:. Archived from 499: 493: 492: 486: 478: 476: 475: 447: 438: 437: 427: 403: 397: 396: 386: 377:(5–6): 455–457. 365:Lowe GD (2003). 362: 353: 352: 334: 319:Jean Cruveilhier 135: 134: 87: 86: 83: 82: 79: 76: 73: 70: 60:triad of Virchow 34: 22: 21: 1422: 1421: 1417: 1416: 1415: 1413: 1412: 1411: 1387: 1386: 1385: 1376: 1325:Hemopericardium 1275: 1228: 1159:Clotting factor 1153: 1097: 1021: 970:Bancroft's sign 953: 944:Virchow's triad 915: 865:Factor V Leiden 821: 798: 788: 758: 749: 745: 736: 734: 725: 724: 720: 707: 703: 694: 690: 681: 679: 670: 669: 665: 658: 631: 627: 618: 616: 607: 606: 602: 593: 591: 587: 572: 566: 562: 525: 521: 512: 510: 501: 500: 496: 480: 479: 473: 471: 464: 448: 441: 412:Br. J. Haematol 404: 400: 363: 356: 349: 335: 331: 327: 307:pathophysiology 284: 214:medical devices 130: 67: 63: 56:Virchow's triad 39:Virchow's triad 20: 17: 12: 11: 5: 1420: 1410: 1409: 1407:Medical triads 1404: 1402:Rudolf Virchow 1399: 1382: 1381: 1378: 1377: 1375: 1374: 1373: 1372: 1364: 1363: 1362: 1357: 1352: 1350:Hemoperitoneum 1347: 1342: 1334: 1333: 1332: 1327: 1322: 1314: 1313: 1312: 1307: 1302: 1297: 1292: 1283: 1281: 1277: 1276: 1274: 1273: 1272: 1271: 1261: 1256: 1251: 1246: 1240: 1238: 1234: 1233: 1230: 1229: 1227: 1226: 1221: 1216: 1211: 1206: 1201: 1196: 1191: 1186: 1185: 1184: 1179: 1174: 1163: 1161: 1155: 1154: 1152: 1151: 1150: 1149: 1144: 1132: 1131: 1130: 1120: 1119: 1118: 1107: 1105: 1099: 1098: 1096: 1095: 1090: 1084: 1083: 1082: 1081: 1076: 1066: 1065: 1064: 1062:Evans syndrome 1049: 1047: 1038: 1031: 1027: 1026: 1023: 1022: 1020: 1019: 1014: 1009: 1008: 1007: 1002: 997: 995:Peabody's sign 992: 987: 982: 977: 972: 961: 959: 955: 954: 952: 951: 946: 941: 936: 931: 925: 923: 917: 916: 914: 913: 908: 907: 906: 896: 895: 894: 889: 887:Thrombocytosis 884: 874: 873: 872: 867: 862: 857: 852: 847: 836: 834: 827: 823: 822: 820: 819: 814: 809: 803: 800: 799: 787: 786: 779: 772: 764: 757: 756: 743: 718: 701: 688: 663: 656: 625: 600: 560: 519: 494: 462: 439: 418:(2): 180–190. 398: 354: 347: 328: 326: 323: 283: 280: 277: 276: 249:hyperviscosity 245: 238: 234: 233: 182: 173: 169: 168: 165:varicose veins 157: 150: 146: 145: 142: 139: 129: 126: 122:Rudolf Virchow 112: 111: 105: 99: 51: 50: 47: 41: 40: 36: 35: 27: 26: 18: 15: 9: 6: 4: 3: 2: 1419: 1408: 1405: 1403: 1400: 1398: 1395: 1394: 1392: 1371: 1368: 1367: 1365: 1361: 1360:Hematosalpinx 1358: 1356: 1353: 1351: 1348: 1346: 1343: 1341: 1338: 1337: 1335: 1331: 1328: 1326: 1323: 1321: 1318: 1317: 1315: 1311: 1308: 1306: 1303: 1301: 1298: 1296: 1293: 1291: 1288: 1287: 1285: 1284: 1282: 1278: 1270: 1267: 1266: 1265: 1262: 1260: 1257: 1255: 1252: 1250: 1247: 1245: 1242: 1241: 1239: 1235: 1225: 1222: 1220: 1217: 1215: 1212: 1210: 1207: 1205: 1202: 1200: 1197: 1195: 1192: 1190: 1187: 1183: 1180: 1178: 1175: 1173: 1170: 1169: 1168: 1165: 1164: 1162: 1160: 1156: 1148: 1145: 1143: 1140: 1139: 1138: 1137: 1133: 1129: 1126: 1125: 1124: 1121: 1117: 1114: 1113: 1112: 1109: 1108: 1106: 1104: 1100: 1094: 1091: 1089: 1086: 1085: 1080: 1077: 1075: 1072: 1071: 1070: 1067: 1063: 1060: 1059: 1058: 1054: 1051: 1050: 1048: 1046: 1042: 1039: 1035: 1032: 1028: 1018: 1015: 1013: 1010: 1006: 1003: 1001: 998: 996: 993: 991: 988: 986: 985:Louvel's sign 983: 981: 980:Lisker's sign 978: 976: 973: 971: 968: 967: 966: 963: 962: 960: 956: 950: 947: 945: 942: 940: 937: 935: 932: 930: 929:Thrombophilia 927: 926: 924: 922: 918: 912: 909: 905: 902: 901: 900: 897: 893: 890: 888: 885: 883: 880: 879: 878: 875: 871: 868: 866: 863: 861: 858: 856: 853: 851: 848: 846: 843: 842: 841: 838: 837: 835: 831: 828: 824: 818: 815: 813: 810: 808: 805: 804: 801: 797: 793: 790:Disorders of 785: 780: 778: 773: 771: 766: 765: 762: 753: 747: 733:on 2016-03-03 732: 728: 722: 716: 715:Who Named It? 712: 711: 705: 698: 692: 678:on 2016-03-04 677: 673: 667: 659: 657:0-88135-113-X 653: 649: 642: 638: 637: 629: 615:on 2016-03-03 614: 610: 604: 590:on 2016-03-05 586: 582: 578: 571: 564: 556: 552: 547: 542: 538: 534: 530: 523: 509:on 2016-03-05 508: 504: 498: 490: 484: 469: 465: 459: 455: 454: 446: 444: 435: 431: 426: 421: 417: 413: 409: 402: 394: 390: 385: 380: 376: 372: 368: 361: 359: 350: 344: 340: 333: 329: 322: 320: 315: 313: 308: 304: 300: 296: 291: 289: 274: 270: 266: 262: 258: 254: 250: 246: 244: 243: 239: 236: 235: 231: 227: 223: 220:of activated 219: 215: 211: 207: 203: 199: 195: 191: 187: 183: 181: 177: 174: 171: 170: 166: 162: 161:venous stasis 158: 156: 155: 151: 148: 147: 143: 140: 137: 136: 133: 125: 123: 120: 117: 109: 106: 103: 100: 98: 95: 94: 93: 91: 85: 61: 57: 48: 46: 42: 37: 33: 28: 23: 1370:Hemarthrosis 1134: 1122: 1110: 1000:Pratt's sign 943: 812:coagulopathy 751: 746: 735:. Retrieved 731:the original 721: 708: 704: 696: 691: 680:. Retrieved 676:the original 666: 647: 635: 628: 617:. Retrieved 613:the original 603: 592:. Retrieved 585:the original 580: 576: 563: 536: 532: 522: 511:. Retrieved 507:the original 497: 472:. Retrieved 452: 415: 411: 401: 374: 370: 338: 332: 316: 292: 285: 253:antithrombin 240: 206:biomaterials 194:hypertension 190:shear stress 179: 175: 152: 131: 113: 59: 55: 54: 1123:aggregation 1005:Rose's sign 975:Homans sign 807:Coagulation 750:Aschoff L. 695:Wiseman R. 186:endothelium 108:Endothelial 102:Hemodynamic 1397:Hematology 1391:Categories 1355:Hematocele 1320:Hemothorax 1295:Hemoptysis 1167:Hemophilia 939:Thrombosis 737:2009-02-10 682:2009-02-10 619:2009-02-10 594:2012-05-09 513:2009-02-10 474:2021-12-06 325:References 297:, whereby 288:thrombosis 138:Virchow's 90:thrombosis 49:thrombosis 1345:Hemobilia 1290:Epistaxis 877:Platelets 710:synd/1223 483:cite book 263:or burn, 226:monocytes 222:platelets 218:membranes 128:The triad 119:physician 1336:abdomen 1259:Petechia 1254:Hematoma 1244:Bleeding 1111:adhesion 1037:By cause 1030:Bleeding 934:Thrombus 833:By cause 826:Clotting 796:clotting 792:bleeding 555:15692259 468:Archived 434:18783400 393:15692260 210:implants 202:bacteria 1305:Hyphema 1280:By site 1264:Purpura 958:By site 299:thrombi 282:History 269:obesity 141:Modern 58:or the 1366:joint 1316:torso 1249:Bruise 1172:A/VIII 654:  553:  460:  432:  391:  345:  312:eponym 265:cancer 261:trauma 154:Stasis 144:Notes 116:German 1286:head 921:Clots 643:–226. 588:(PDF) 573:(PDF) 303:veins 1182:C/XI 1177:B/IX 794:and 652:ISBN 551:PMID 489:link 458:ISBN 430:PMID 389:PMID 343:ISBN 1074:TTP 1057:ITP 899:DIC 713:at 641:219 541:doi 420:doi 416:143 379:doi 228:in 212:or 208:of 192:or 178:or 75:ɪər 1393:: 1069:TM 1055:: 581:81 579:. 575:. 549:. 537:33 535:. 531:. 485:}} 481:{{ 466:. 442:^ 428:. 414:. 410:. 387:. 375:33 373:. 369:. 357:^ 232:. 216:, 92:. 81:oʊ 783:e 776:t 769:v 660:. 597:. 557:. 543:: 491:) 477:. 436:. 422:: 395:. 381:: 351:. 84:/ 78:k 72:f 69:ˈ 66:/ 62:(

Index


Differential diagnosis
/ˈfɪərk/
thrombosis
Hypercoagulability
Hemodynamic
Endothelial
German
physician
Rudolf Virchow
Stasis
venous stasis
varicose veins
endothelium
shear stress
hypertension
surface phenomena
bacteria
biomaterials
implants
medical devices
membranes
platelets
monocytes
chronic inflammation
Hypercoagulability
hyperviscosity
antithrombin
nephrotic syndrome
trauma

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.